MAXCYTE, INC. Net Income Loss

Quick Answer

MAXCYTE, INC. reported Net Income Loss of -$44.63 million for the year ending 2025.

  • MAXCYTE, INC. showed a decrease of -8.7% in Net Income Loss from 2024 to 2025.
  • This data is from MAXCYTE, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), MAXCYTE, INC.'s Net Income Loss has declined by 246.1%.
  • Historical annual values: Fiscal year 2025: -$44.63 million | Fiscal year 2024: -$41.06 million | Fiscal year 2023: -$37.92 million | Fiscal year 2022: -$23.57 million | Fiscal year 2021: -$19.08 million | Fiscal year 2020: -$11.82 million | Fiscal year 2019: -$12.90 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: